Edition:
India

Alembic Pharmaceuticals Ltd (ALEM.NS)

ALEM.NS on National Stock Exchange of India

549.25INR
17 Jan 2018
Change (% chg)

Rs9.95 (+1.84%)
Prev Close
Rs539.30
Open
Rs537.10
Day's High
Rs551.45
Day's Low
Rs530.00
Volume
50,383
Avg. Vol
61,700
52-wk High
Rs648.00
52-wk Low
Rs469.85

Select another date:

Tue, Dec 26 2017

BRIEF-Alembic Pharmaceuticals Says U.S. FDA Grants Orphan-Drug Designation To Rhizen Pharmaceuticals

* U.S. FDA GRANTS ORPHAN-DRUG DESIGNATION FOR TENALISIB TO RHIZEN PHARMACEUTICALS S.A. (RHIZEN) Source text - http://bit.ly/2C7DIYd Further company coverage:

BRIEF-Alembic Pharma Gets U.S. FDA Nod For Generic Drug to Treat Overactive Bladder

* DRUG IS INTENDED TO TREAT OVERACTIVE BLADDER Source text: http://bit.ly/2BVyJWK Further company coverage:

MEDIA-India's Alembic Pharma plans greenfield projects to feed global market - Business Line

- Note: Reuters has not verified this story and does not vouch for its accuracy

BRIEF-India's Alembic Pharma Sept-qtr consol PAT rises

* Says U.S. formulations business continues to face price erosion on some key products; India branded business showing signs of recovery‍​‍​

BRIEF-Alembic Pharma buys generic drug developer Orit Laboratories

* Says ‍co buys U.S. based generic drug developer Orit Laboratories LLC​ Source text: http://bit.ly/2z3AKCI Further company coverage:

BRIEF-Alembic Pharmaceuticals gets EU GMP certificate for audit conducted at Panelav

* Alembic Pharmaceuticals - gets EU GMP certificate for audit conducted at its formulation facility at Panelav from 8th to 10th Aug Source text for Eikon: Further company coverage:

BRIEF-Alembic Pharma Ltd says sold Baddi plant to Scott Edil Pharmacia Ltd

* Says sold Baddi, Solan plant to Scott Edil Pharmacia Ltd on slump sale basis

BRIEF-Alembic Pharmaceuticals sells formulations manufacturing facility at Baddi to Scott Edil Pharmacia

* Alembic pharmaceuticals says sold on slump sale basis its formulations manufacturing facility at Baddi, dist. Solan to Scott Edil Pharmacia Limited Source text for Eikon: Further company coverage:

BRIEF-India's Alembic Pharmaceuticals says fire at Algerian JV plant

* Says there was a fire incident at Algerian joint venture plant at Constantine, Algeria Constantine, Algeria

BRIEF-Alembic Pharmaceuticals gets U.S. FDA approval for Doxycycline Capsules USP, 75 mg & 100 mg

* Says Alembic Pharmaceuticals Limited receives USFDA approval for Doxycycline Capsules USP, 75 mg and 100 Mg.

Select another date: